Nirav Pravinkumar Trivedi
About Nirav Pravinkumar Trivedi
Data last updated:
Nirav Pravinkumar Trivedi is a Director at Zasya Life Sciences Private Limited (since 2022), Director at Neovant Therapeutics Private Limited (since 2023) and Director at Clinoquent Research Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Pharma, Professional Services and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹12.45 Cr; the largest is Zasya Life Sciences Private Limited at ₹9.37 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zasya Life Sciences Private Limited U73100GJ2021PTC126759 | Director | 13 Jan 2022 | 2021 | ₹9.37 Cr (FY 2025) | Active |
 Neovant Therapeutics Private Limited U21002GJ2023PTC138826 | Director | 10 Mar 2023 | 2023 | ₹2.66 Cr (FY 2025) | Active |
| Clinoquent Research Private Limited U72100GJ2023PTC144116 | Director | 23 Aug 2023 | 2023 | ₹42.3 Lakh (FY 2025) | Active |
| Trivedi Oncodigital Llp AAK-5164 | Designated Partner | 06 Sep 2017 | 2017 | Active | |
 Shashwat Oncocare Llp AAJ-8324 | Designated Partner | 29 Jun 2017 | 2017 | Active | |
| Onconet Cancer Network (India) Llp AAF-3888 | Designated Partner | 28 Dec 2015 | 2015 | Active |
Board colleagues of Nirav Pravinkumar Trivedi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirav Pravinkumar Trivedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirav Pravinkumar Trivedi
Nirav Pravinkumar Trivedi currently holds 6 directorships: Zasya Life Sciences Private Limited (Director, since 13 Jan 2022, revenue ₹9.37 Cr (FY 2025)); Neovant Therapeutics Private Limited (Director, since 10 Mar 2023, revenue ₹2.66 Cr (FY 2025)); Clinoquent Research Private Limited (Director, since 23 Aug 2023, revenue ₹42.3 Lakh (FY 2025)); Trivedi Oncodigital Llp (Designated Partner, since 06 Sep 2017); Shashwat Oncocare Llp (Designated Partner, since 29 Jun 2017); and 1 more.
Nirav Pravinkumar Trivedi was first appointed on 28 Dec 2015 as Designated Partner at Onconet Cancer Network (India) Llp. The most recent appointment on record is 23 Aug 2023 at Clinoquent Research Private Limited.
The 3 current companies of Nirav Pravinkumar Trivedi that report revenue have a combined latest revenue of ₹12.45 Cr: Zasya Life Sciences Private Limited ₹9.37 Cr (FY 2025); Neovant Therapeutics Private Limited ₹2.66 Cr (FY 2025); Clinoquent Research Private Limited ₹42.3 Lakh (FY 2025).
The current boards of Nirav Pravinkumar Trivedi's companies include Dilip Shankarbhai Chaudhary (Zasya Life Sciences Private Limited), Ramakrishna Guduru (Zasya Life Sciences Private Limited), Ramaswamy Akula (Zasya Life Sciences Private Limited), Siddhanand Narendranath Padukone (Zasya Life Sciences Private Limited), Dashrathbhai Kalidas Patel (Neovant Therapeutics Private Limited), Jagdish Madhavlal Chaudhary (Neovant Therapeutics Private Limited), among others.